Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−14,000−100.0%Sold outHolders
Q1 202614,000$563.2K0.3%00.0%UnchangedHolders
Q4 202514,000$351.7K0.2%00.0%UnchangedHolders
Q3 202514,000$316.8K0.2%00.0%UnchangedHolders
Q2 202514,000$242.3K0.2%00.0%UnchangedHolders
Q1 202514,000$306.2K0.3%00.0%UnchangedHolders
Q4 202414,000$446.7K0.4%00.0%UnchangedHolders
Q3 202414,000$403.8K0.3%00.0%UnchangedHolders
Q2 202414,000$537.0K0.5%−4,000−22.2%ReducedHolders
Q1 202418,000$1.06M0.9%00.0%UnchangedHolders
Q4 202318,000$1.08M0.8%00.0%UnchangedHolders
Q3 202318,000$684.7K0.6%+6,000+50.0%AddedHolders
Q2 202312,000$1.09M0.8%00.0%UnchangedHolders
Q1 202312,000$792.0K0.6%00.0%UnchangedHolders
Q4 202212,000$621.0K0.4%00.0%UnchangedHolders
Q3 202212,000$820.0K0.6%00.0%UnchangedHolders
Q2 202212,000$543.0K0.4%00.0%UnchangedHolders
Q1 202212,000$610.0K0.4%00.0%UnchangedHolders
Q4 202112,000$567.0K0.4%00.0%UnchangedHolders
Q3 202112,000$396.0K0.3%+4,000+50.0%AddedHolders
Q2 20218,000$506.0K0.3%00.0%UnchangedHolders
Q1 20218,000$343.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.